Discovery of nonpeptide 3,4-dihydroquinazoline-4-carboxamides as potent and selective sst2 agonists
作者:Jian Zhao、Shimiao Wang、Sangdon Han、Sun Hee Kim、Ana Karin Kusnetzow、Julie Nguyen、Elizabeth Rico-Bautista、Hannah Tan、Stephen F. Betz、R. Scott Struthers、Yunfei Zhu
DOI:10.1016/j.bmcl.2020.127391
日期:2020.9
Nonpeptide sst2 agonists can provide a new treatment option for patients with acromegaly, carcinoid tumors, and neuroendocrine tumors. Our medicinal chemistry efforts have led to the discovery of novel 3,4-dihy-droquinazoline-4-carboxamides as sst2 agonists. This class of molecules exhibits excellent human sst2 potency and selectivity against sst1, sst3, sst4 and sst5 receptors. Leading compound 3-(3-chloro-5-methylphenyl)-6-(3- fluoro-2-hydroxyphenyl)-N,7-dimethyl-N-[(2S)-pyrrolidin-2-yl]methyl}-3,4-dihydroquinazoline-4-carbox-amide (28) showed no inhibition of major CYP450 enzymes (2C9, 2C19, 2D6 and 3A4) and weak inhibition of the hERG channel.